A Comparison Study of UHE-103 Cream in Subjects With Moccasin Type Tinea Pedis (NCT03897257) | Clinical Trial Compass
CompletedPhase 2
A Comparison Study of UHE-103 Cream in Subjects With Moccasin Type Tinea Pedis
United States240 participantsStarted 2019-03-15
Plain-language summary
The study is being done to determine and compare the safety and effectiveness of an investigational combination therapy (low and high concentrations) versus mono-therapy (low and high concentrations) or mono-therapy (fixed concentration) in subjects with moccasin type tinea pedis.
Who can participate
Age range16 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Male or non-pregnant female, 16 years of age or older.
* Clinical diagnosis of moccasin type tinea pedis
* Microscopic evidence (positive KOH) of the presence of fungi
* Provided written informed consent/assent
* In general good health
Exclusion Criteria:
* Pregnant or lactating or planning to get pregnant while on the study
* Has concurrent tinea infection (e.g., tinea versicolor, tinea cruris)
* Other skin disease which might interfere with the evaluation of tinea pedis
* History of diabetes mellitus or is immunocompromised
* Currently enrolled in an investigational drug or device study
* Used an investigational drug or investigational device treatment within 30 days prior to Visit 1 (Study Day 1)/Baseline
Other protocol defined inclusion or exclusion criteria assessed by the study staff may apply.